← Eichor
Study identifier: NCT06610669 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

The Prevalence of Hyper-Lp(a)-Emia in the PMMHRI-Lp(a) Registry

Condition: Lipoprotein(a), Hyper-Lp(a)-Emia  ·  Sponsor: Polish Mother Memorial Hospital Research Institute

PhaseN/A
Planned participants2000
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersNo

About this study

The PMMHRI-Lp(a)-Registry is a non-interventional, single-center registry conducted in the Polish Mother's Memorial Hospital Research Institute (PMMHRI). The PMMHRI-Lp(a)-Registry was established in January 2022. Since then, all consecutive patients of the Department of Cardiology and Adult Congenital Heart Diseases, Department of Endocrinology, and outpatient cardiology and endocrinology clinics with the measured Lp(a) concentration have been included.

This description comes directly from the study's public registry record.

Talk to the study team

Maciej Banach, MD,PhD,FNLA,FAHA,FESC,FASA  ·  +48 42 2711599  ·  maciej.banach@icloud.com

Always discuss trial participation with your own doctor first.

Locations (1)

Polish Mother Memorial Research InstituteLodz, PolandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06610669